Andrew Fein
Stock Analyst at HC Wainwright & Co.
(4.54)
# 197
Out of 5,180 analysts
563
Total ratings
52.16%
Success rate
24.16%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KALV KalVista Pharmaceuticals | Maintains: Buy | $27 → $37 | $20.13 | +83.81% | 17 | Jan 9, 2026 | |
| AMLX Amylyx Pharmaceuticals | Maintains: Buy | $16 → $20 | $13.90 | +43.88% | 21 | Nov 7, 2025 | |
| ALEC Alector | Maintains: Buy | $10 → $5 | $2.15 | +132.56% | 11 | Oct 22, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $400 → $500 | $592.98 | -15.68% | 17 | Sep 5, 2025 | |
| BIIB Biogen | Maintains: Buy | $187 → $194 | $183.33 | +5.82% | 22 | Aug 1, 2025 | |
| FULC Fulcrum Therapeutics | Upgrades: Buy | $4 → $12 | $7.67 | +56.45% | 18 | Jul 29, 2025 | |
| CADL Candel Therapeutics | Assumes: Buy | $23 | $4.90 | +369.39% | 1 | Jun 30, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $54 → $60 | $83.29 | -27.96% | 8 | Jun 26, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $32 | $22.26 | +43.76% | 20 | Jun 26, 2025 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Buy | $550 | $446.54 | +23.17% | 27 | Jun 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $163.52 | -26.61% | 15 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.77 | +351.98% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $2 | $5.46 | -63.37% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $35 | $37.74 | -7.26% | 14 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $14 | $9.72 | +44.03% | 18 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $35 | $32.56 | +7.49% | 14 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $14 | $5.54 | +152.71% | 16 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $48.20 | +55.60% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $18.13 | +109.60% | 12 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $25 | $11.03 | +126.65% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $32 | $19.20 | +66.67% | 22 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $9.52 | +215.13% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $16 | $20.98 | -23.74% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $24 | $10.60 | +126.42% | 19 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $2.75 | +336.36% | 16 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $124.65 | -69.51% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $168 | $131.74 | +27.52% | 20 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $11 | $2.36 | +366.10% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.34 | +327.35% | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $7.25 | +203.45% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $120 → $20 | $24.91 | -19.71% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $1.62 | +640.74% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $4.78 | +171.97% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $8.34 | +31.89% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $5.21 | +341.46% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.01 | +1,385.15% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $24.76 | +41.36% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $9.39 | +698.72% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $2.63 | +166.16% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.29 | +675.19% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.50 | +29,900.00% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $200 → $60 | $14.46 | +314.94% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $1.69 | +787.57% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $0.76 | +5,143.15% | 3 | Mar 16, 2022 |
KalVista Pharmaceuticals
Jan 9, 2026
Maintains: Buy
Price Target: $27 → $37
Current: $20.13
Upside: +83.81%
Amylyx Pharmaceuticals
Nov 7, 2025
Maintains: Buy
Price Target: $16 → $20
Current: $13.90
Upside: +43.88%
Alector
Oct 22, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $2.15
Upside: +132.56%
United Therapeutics
Sep 5, 2025
Maintains: Buy
Price Target: $400 → $500
Current: $592.98
Upside: -15.68%
Biogen
Aug 1, 2025
Maintains: Buy
Price Target: $187 → $194
Current: $183.33
Upside: +5.82%
Fulcrum Therapeutics
Jul 29, 2025
Upgrades: Buy
Price Target: $4 → $12
Current: $7.67
Upside: +56.45%
Candel Therapeutics
Jun 30, 2025
Assumes: Buy
Price Target: $23
Current: $4.90
Upside: +369.39%
Kymera Therapeutics
Jun 26, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $83.29
Upside: -27.96%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $32
Current: $22.26
Upside: +43.76%
Vertex Pharmaceuticals
Jun 23, 2025
Reiterates: Buy
Price Target: $550
Current: $446.54
Upside: +23.17%
Jun 11, 2025
Maintains: Buy
Price Target: $90 → $120
Current: $163.52
Upside: -26.61%
May 29, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $1.77
Upside: +351.98%
May 29, 2025
Downgrades: Neutral
Price Target: $6 → $2
Current: $5.46
Upside: -63.37%
May 28, 2025
Maintains: Buy
Price Target: $29 → $35
Current: $37.74
Upside: -7.26%
May 27, 2025
Maintains: Buy
Price Target: $30 → $14
Current: $9.72
Upside: +44.03%
May 14, 2025
Maintains: Buy
Price Target: $47 → $35
Current: $32.56
Upside: +7.49%
May 14, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $5.54
Upside: +152.71%
May 12, 2025
Maintains: Buy
Price Target: $80 → $75
Current: $48.20
Upside: +55.60%
May 9, 2025
Maintains: Buy
Price Target: $46 → $38
Current: $18.13
Upside: +109.60%
May 8, 2025
Maintains: Buy
Price Target: $40 → $25
Current: $11.03
Upside: +126.65%
May 7, 2025
Maintains: Buy
Price Target: $80 → $32
Current: $19.20
Upside: +66.67%
May 6, 2025
Reiterates: Buy
Price Target: $30
Current: $9.52
Upside: +215.13%
May 5, 2025
Maintains: Buy
Price Target: $7 → $16
Current: $20.98
Upside: -23.74%
May 2, 2025
Maintains: Buy
Price Target: $81 → $24
Current: $10.60
Upside: +126.42%
May 1, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $2.75
Upside: +336.36%
Apr 30, 2025
Reiterates: Buy
Price Target: $38
Current: $124.65
Upside: -69.51%
Apr 22, 2025
Maintains: Buy
Price Target: $185 → $168
Current: $131.74
Upside: +27.52%
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $2.36
Upside: +366.10%
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $2.34
Upside: +327.35%
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $7.25
Upside: +203.45%
Mar 17, 2025
Downgrades: Neutral
Price Target: $120 → $20
Current: $24.91
Upside: -19.71%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $1.62
Upside: +640.74%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $4.78
Upside: +171.97%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $8.34
Upside: +31.89%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $5.21
Upside: +341.46%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $1.01
Upside: +1,385.15%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $24.76
Upside: +41.36%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $9.39
Upside: +698.72%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $2.63
Upside: +166.16%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $1.29
Upside: +675.19%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $0.50
Upside: +29,900.00%
May 5, 2022
Downgrades: Neutral
Price Target: $200 → $60
Current: $14.46
Upside: +314.94%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $1.69
Upside: +787.57%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $0.76
Upside: +5,143.15%